Atlas Trials

Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT

Clinical trial NCT07511127 · RECRUITING

Trial details

NCT number
NCT07511127
Sponsor
Ruijin Hospital
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hematologic Malignancy
Start date
2026-02-28
Primary completion
2027-12-31
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.